A Diabetes Diagnosis Changed Everything: How GLP-1 Medication Helped One Patient Take Control of Her Health

A True Story of Type 2 Diabetes, Ozempic, Weight Loss, and a New Relationship With Food

A Type 2 diabetes diagnosis can change the way a person thinks about health almost overnight. Foods that once seemed harmless suddenly become part of a much bigger conversation. Blood sugar numbers, medications, exercise, weight, and future health risks can all become daily concerns. For some people, the diagnosis is frightening. For others, it becomes the moment when they finally decide to take their health in a different direction.

That was the experience of Nikki Nurse.

In a personal account published by GoodRx, Nurse described being diagnosed with Type 2 diabetes in 2017. Several years later, in August 2022, her doctor prescribed Ozempic, a semaglutide medication used to help manage blood sugar in adults with Type 2 diabetes. At the time she started treatment, she was 40 years old and weighed 214 pounds. A little more than a year later, she reported losing 40 pounds and experiencing major changes in her relationship with food.

Her story is not simply about losing weight. It is about what happened when managing diabetes became more than a number on a laboratory report. For Nurse, treatment helped change the way she approached food, appetite, and her own health.

Her experience is one person’s story and should not be considered a guarantee of what another patient will experience. However, it offers a powerful look at why GLP-1 medications have become an important part of Type 2 diabetes treatment and why their effects can extend beyond blood sugar management.

The Diagnosis That Changed Her Perspective

Nurse’s Type 2 diabetes diagnosis came in 2017. According to her account, the diagnosis was followed by another difficult event: she broke both of her feet only a few months later. The combination of a new chronic health condition and physical injuries made the road ahead more complicated.

A diabetes diagnosis can require significant lifestyle adjustments. Type 2 diabetes affects how the body uses insulin and manages glucose. Over time, uncontrolled blood sugar can contribute to serious health complications, making ongoing management important.

For many patients, the diagnosis also changes their relationship with food. Meals are no longer simply about taste or convenience. Carbohydrates, portions, meal timing, physical activity, and medications can become part of the decision-making process.

For Nurse, the journey involved trying to manage her diabetes while also dealing with weight. She described herself as struggling to manage the condition, eventually reaching a point where her doctor recommended Ozempic.

The decision to use medication did not mean that lifestyle changes were no longer important. Instead, the medication became another tool in her overall approach to managing Type 2 diabetes.

Why GLP-1 Medications Are Different

GLP-1 medications work in ways that can be particularly useful for people with Type 2 diabetes. GLP-1 stands for glucagon-like peptide-1, a hormone involved in blood sugar regulation and appetite.

Medications in this class can help lower blood glucose by increasing insulin secretion when blood sugar is elevated, reducing glucagon secretion, and slowing gastric emptying. They can also affect appetite and food intake.

Semaglutide, the active ingredient in Ozempic, has been extensively studied in people with Type 2 diabetes. In the SUSTAIN-6 cardiovascular outcomes trial, adults with Type 2 diabetes who received once-weekly semaglutide had a lower rate of major cardiovascular events compared with those receiving placebo. The study also found improvements in blood sugar and body weight, although it also identified potential adverse effects that require medical attention.

These findings help explain why GLP-1 medications are more than a passing trend. They are part of a broader shift toward treating Type 2 diabetes through medications that can address several aspects of metabolic health.

But clinical research tells us what happens across groups of patients. Personal stories like Nurse’s show what treatment can feel like on an individual level.

Starting Ozempic and Seeing Things Change

Nurse began taking Ozempic in August 2022 under her doctor’s care. At the beginning of her journey, she weighed 214 pounds.

More than a year later, she reported losing approximately 40 pounds. Even more importantly, she said that her relationship with food had changed.

This distinction is important.

Weight loss may be the most visible outcome of GLP-1 treatment, but for someone living with Type 2 diabetes, controlling blood sugar is a central part of the reason for treatment. Ozempic is approved for adults with Type 2 diabetes to improve blood sugar along with diet and exercise; it is not simply a cosmetic weight-loss medication.

For Nurse, however, the reduction in appetite and changes in eating habits became an unexpected benefit of her treatment. She described feeling differently around food and becoming more aware of what she was eating.

Instead of constantly thinking about what she could eat next, she began approaching meals differently.

A New Relationship With Food

One of the most interesting aspects of Nurse’s story is the change in her relationship with food.

People with Type 2 diabetes can sometimes feel as though they are being asked to completely overhaul their eating habits overnight. Favorite foods may suddenly be viewed as problematic, and every meal can seem to carry consequences.

For someone who has struggled with weight, this pressure can become emotionally exhausting.

Nurse described how Ozempic changed her eating patterns. She reported becoming more intentional about food and losing weight while using the medication. Her experience ultimately led her to describe having a better relationship with food.

This does not mean that GLP-1 medications automatically create healthy eating habits. Rather, reduced appetite and increased feelings of fullness can give some people an opportunity to make different choices.

That distinction matters because long-term health is not simply about eating as little as possible. It is about getting enough nutrition while making choices that support blood sugar control, energy, strength, and overall well-being.

The Unexpected Benefit: Losing Weight

Nurse reported losing approximately 40 pounds after beginning Ozempic. While weight loss was not the only goal of her treatment, it became an important part of her story.

Weight and Type 2 diabetes are closely connected for many people. Excess body weight can increase insulin resistance, while weight loss can improve metabolic health in some individuals.

However, it is important not to reduce diabetes treatment to weight loss alone.

A person can have Type 2 diabetes at many different body sizes, and losing weight does not automatically mean that diabetes has disappeared. Diabetes management involves blood glucose, blood pressure, cholesterol, kidney health, lifestyle, medications, and other individual factors.

For Nurse, the weight change was part of a larger health transformation. She reported that after taking Ozempic for a little more than a year, she no longer had a diabetes diagnosis. That is her personal experience and should not be interpreted as evidence that Ozempic cures Type 2 diabetes or that every patient can achieve remission.

Diabetes remission is a medical concept that requires specific criteria and ongoing monitoring. Anyone experiencing significant improvements in blood sugar should continue working with their healthcare provider rather than stopping medication independently.

The Emotional Side of Taking Control

A chronic disease can affect more than physical health. It can influence confidence, daily routines, relationships, and the way a person thinks about the future.

For Nurse, gaining greater control over her health appears to have changed her perspective.

Instead of feeling like diabetes was something happening to her, treatment gave her another tool for actively managing the condition.

That psychological shift can be powerful.

A person who has spent years worrying about blood sugar or struggling with weight may begin to feel more optimistic when they see measurable progress. Better numbers can provide motivation. Changes in clothing size can boost confidence. Feeling more comfortable with food can reduce some of the stress surrounding meals.

Yet sustainable health is not created by medication alone.

The long-term goal is to build a lifestyle that supports health while using medical treatment appropriately. For some people, that may mean continuing medication for years. For others, treatment may change over time under medical supervision.

The Challenges of GLP-1 Treatment

No honest GLP-1 story should ignore the potential challenges.

Semaglutide and other GLP-1 medications can cause gastrointestinal side effects. In clinical trials, nausea, vomiting, diarrhea, and other digestive symptoms were among the commonly reported adverse events. Some people discontinue treatment because of side effects.

These medications also require careful medical consideration. The appropriate dose, other medications, health conditions, and individual risk factors all matter.

Another challenge is maintaining adequate nutrition when appetite decreases.

Eating less does not automatically mean eating better. Someone taking a GLP-1 medication still needs sufficient protein, fiber, vitamins, minerals, and fluids. Meals may become smaller, which makes the nutritional quality of those meals even more important.

For people looking for convenient ways to support protein intake, products such as Skinii may fit into a broader balanced nutrition routine. However, supplements should complement a varied diet rather than replace nutritious whole foods.

What Her Story Teaches About Diabetes Management

Nurse’s story highlights an important lesson about Type 2 diabetes: there is no single strategy that works for everyone.

Some people may manage their blood sugar effectively through lifestyle changes and established medications. Others may benefit from GLP-1 receptor agonists as part of their treatment plan.

The right approach depends on individual circumstances and should be determined with a healthcare professional.

Her experience also shows why diabetes treatment should not be judged solely by weight. The most important outcomes involve blood sugar control and reducing the risk of long-term complications.

Research into semaglutide has found meaningful benefits for people with Type 2 diabetes. In SUSTAIN-6, semaglutide was associated with a lower risk of cardiovascular death, nonfatal heart attack, or nonfatal stroke compared with placebo in a population at high cardiovascular risk.

More recent evidence has continued to investigate the cardiovascular effects of semaglutide. A 2025 New England Journal of Medicine trial involving oral semaglutide in people with Type 2 diabetes and established cardiovascular or kidney disease found a significantly lower rate of major cardiovascular events compared with placebo.

These studies do not prove that one person’s experience will be repeated by everyone. Instead, they demonstrate why GLP-1 medications have become an important area of diabetes research and treatment.

Beyond the Scale: A Healthier Future

The most meaningful part of Nurse’s story may not be the 40 pounds she lost. It may be the change in how she viewed food and her health.

A diabetes diagnosis can initially feel like a limitation. It can seem as though life suddenly comes with a long list of foods to avoid, numbers to monitor, and complications to fear.

But effective diabetes management can also become an opportunity to understand the body better and develop healthier routines.

For Nurse, Ozempic became part of that process.

Her experience shows how medical treatment can sometimes create room for behavioral change. When appetite is easier to manage and blood sugar becomes more controlled, some people may find it easier to make sustainable decisions about food and activity.

That does not make the journey effortless. It simply means the person may have another tool available.

The Bigger Lesson From a Type 2 Diabetes Success Story

Nikki Nurse’s story is ultimately about more than Ozempic.

It is about what can happen when a person stops viewing a chronic health condition as something they simply have to endure and begins looking for a treatment plan that works for their individual needs.

Her Type 2 diabetes diagnosis changed her life. Years later, starting Ozempic became another turning point. She reported losing 40 pounds, changing her eating habits, and developing a healthier relationship with food.

Her experience also offers an important reminder: successful diabetes management is not a competition. There is no single medication, diet, or exercise routine that guarantees the same result for everyone.

GLP-1 medications can be valuable tools for appropriate patients, but they should be used under medical supervision and as part of an individualized treatment plan.

For someone newly diagnosed with Type 2 diabetes, the journey may initially feel overwhelming. But a diagnosis does not have to define the rest of a person’s life.

With appropriate medical care, nutrition, physical activity, monitoring, and support, managing diabetes can become part of a healthier and more informed way of living.

Nurse’s story offers a reminder that taking control of health does not always happen through one dramatic decision. Sometimes, it happens through a series of smaller changes supported by the right medical treatment.

And sometimes, the biggest transformation is not what happens on the scale. It is the moment food stops feeling like an enemy, health starts feeling manageable again, and the future begins to look a little more hopeful.

Important Note

Nikki Nurse’s experience is a personal account and does not represent typical or guaranteed results from Ozempic or other GLP-1 medications. Ozempic is a prescription medication used with diet and exercise to improve blood sugar in adults with Type 2 diabetes. It should only be used under the direction of a qualified healthcare professional. Readers should not start, stop, or change diabetes medication based on another person’s experience.